anti-CD20 antibody + anti-CD38 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-CD20 antibody + anti-CD38 antibody, covering 2023-10-31 to 2023-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome [Phase 2]